IGI Labs (IG) Tops Q2 EPS by 4c

Go back to IGI Labs (IG) Tops Q2 EPS by 4c

Roth Capital Upgrades IGI Laboratories (IG) to Buy; Sees 2016 at Break-Out Year

July 24, 2015 6:58 AM EDT

Roth Capital upgraded IGI Laboratories (NYSE: IG) from Neutral to Buy with a price target of $11.00 (from $7.00), saying 2016 could be a break-out year.

Analyst Scott Henry commented, "The impetus for our upgrade is stabilization of the econazole nitrate franchise, a lower valuation, and... More